Жанры
Авторы
Контакты
О сайте
Книжные новинки
Популярные книги
Найти
Главная
Авторы
Группа авторов
Recent Advances in Dialysis Therapy in Japan
Читать книгу Recent Advances in Dialysis Therapy in Japan - Группа авторов - Страница 1
Оглавление
Предыдущая
Следующая
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
...
107
Оглавление
Купить и скачать книгу
Вернуться на страницу книги Recent Advances in Dialysis Therapy in Japan
Оглавление
Страница 1
Страница 2
Contributions to Nephrology
Recent Advances in Dialysis Therapy in Japan
Страница 5
Contents
Preface
Страница 8
Eosinophilic Inflammation in Peritoneal Fibrosis Patients Undergoing Peritoneal Dialysis
Abstract
Expectations and Challenges of PD Therapy
Pathogenesis of EPS and the Innate Immune System
Eosinophils and the Innate Immune System
Towards Restriction of EPS
Disclosure Statement
Funding Sources
References
Страница 18
Current Perspectives on Sudden Cardiac Death in Hemodialysis Patients
Abstract
SCD in Japanese Dialysis Patients
The Definition of Sudden Death
HD Patient-Specific Underlying Cardiac Abnormalities Related to SCD
Is Ventricular Fatal Arrhythmia the Main Cause of SCD in HD Patients?
HD Cycle and Onset of SCD
Long QT Interval due to Dialysis Solution
Conclusions
Disclosure Statement
Funding Sources
References
Страница 31
Strategy for Prevention of Left Ventricular Remodeling in Predialysis and Dialysis Patients
Abstract
Methods Prospective Study Cohort (CKD Stage 5D Patients)
Retrospective Study Design (Initiation of Dialysis in Predialysis Patients)
Retrospective Study Design (CKD Stage 1–5 Patients)
Echocardiographic Examinations
Statistical Analyses
Results CKD (Stage 5D: PD) Patients
CKD (Stage 5D: HD) Patients
CKD (Stage 5: Initiation of Dialysis in Predialysis Patients)
CKD (Stages 1–5) Cross-Sectional Study
CKD (Stages 1–5) Longitudinal Study
Discussion
Conclusions
Acknowledgments
Disclosure Statement
Funding Sources
References
Страница 50
Asymptomatic Cerebrovascular Disease in Dialysis Patients
Abstract
Stroke in Dialysis Patients
Asymptomatic Cerebral Small Vessel Disease in Dialysis Patients
Silent Brain Infarction
White Matter Hyperintensities
Cerebral Microbleeds
Conclusion
References
Страница 60
Brain Atrophy and Cognitive Impairment in Chronic Kidney Disease
Abstract
Brain Atrophy in Dialysis Patients Brain Atrophy in Patients Undergoing Hemodialysis
Brain Atrophy in Patients Undergoing Peritoneal Dialysis
Relationship between Brain Atrophy and Cognitive Function in CKD Patients
Factors Associated with Cognitive Impairment
Anemia and Cognitive Impairment
Dialysis Modalities and Cognitive Impairment
Relationship between CKD and Dementia
Mechanism of Cognitive Impairment in CKD Oxidative Stress
Renin-Angiotensin System
Conclusions
Acknowledgements
Disclosure Statement
Funding Sources
References
Страница 77
Targets and Therapeutics for Glycemic Control in Diabetes Patients on Hemodialysis
Abstract
Glycemic Control Index and Target Value Plasma Glucose Levels
Target Casual Plasma Glucose Levels
Medium- to Long-Term Glycemic Control Index
Target GA Levels
Frequency of Monitoring Glycemic Control Indicators
Hemodialysis-Induced Hyperglycemia
Treatment Dietary Treatment
Drug Treatment Oral Hypoglycemic Agents
Insulin Therapy
Injection of Drugs Other Than Insulin: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Hypoglycemia
Conclusion
Conflicts of Interest
Funding Sources
References
Страница 95
Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels
Abstract
Patients and Methods
Biochemical Assays and Other Measurements
Statistical Analysis
Results
Discussion
Conclusions
Statement of Ethics
Disclosure Statement
References
{buyButton}
Подняться наверх
